Rapport Therapeutics, Inc. Common Stock (RAPP) — Defensive Interval Ratio
Rapport Therapeutics, Inc. Common Stock (RAPP) has a Defensive Interval Ratio of 4787 days as of June 2026. Defensive assets of $372.76 Million (cash $-, short-term investments $372.46 Million, receivables $293.00K) cover 4787 days of daily cash needs of $77.87K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Rapport Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Rapport Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 4787 days, meaning defensive assets of $372.76 Million can fund 4787 days of operations without new revenue. For the complete balance sheet picture, see how large is Rapport Therapeutics, Inc. Common Stock's balance sheet.
Annual Defensive Interval Ratio for Rapport Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Rapport Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Rapport Therapeutics, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 8391 days | $437.89 Million | $52.19K/day | $- | $437.89 Million | ▼ -1954 days |
| 2024 | 10345 days | $248.47 Million | $24.02K/day | $- | $248.47 Million | ▲ +7139 days |
| 2023 | 3205 days | $77.31 Million | $24.12K/day | $- | $77.31 Million | ▲ +3205 days |
| 2022 | 0 days | $0.00 | $4.56K/day | $- | $0.00 | — |